| 4th Dec 2024 6:03 pm |
RNS |
Retail Offer for up to £1 million |
| 4th Dec 2024 5:59 pm |
RNS |
Proposed fundraise in excess of £8.5 million |
| 4th Dec 2024 7:00 am |
RNS |
Second Commercial License Agreement with Genmab |
| 18th Nov 2024 7:00 am |
RNS |
Positive data from Phase 2 SCOPE trial with SCIB1 |
| 25th Oct 2024 3:26 pm |
RNS |
Result of Annual General Meeting |
| 24th Oct 2024 7:00 am |
RNS |
Holding(s) in Company |
| 22nd Oct 2024 7:00 am |
RNS |
Scancell Appoints Dr Phil L’Huillier as CEO |
| 1st Oct 2024 7:00 am |
RNS |
Notice of AGM |
| 24th Sep 2024 7:00 am |
RNS |
Results Year Ended 30 April 2024 |
| 18th Sep 2024 7:00 am |
RNS |
Notice of Final Results |
| 17th Sep 2024 7:00 am |
RNS |
Strategic Partnership with PharmaJet |
| 2nd Sep 2024 7:00 am |
RNS |
Scancell to attend upcoming conferences |
| 30th Jul 2024 7:17 am |
RNS |
Scancell Appoints Dr Nermeen Varawalla as CMO |
| 30th Jul 2024 7:00 am |
RNS |
Scancell Appoints Dr Nermeen Varawalla as CMO |
| 24th Jul 2024 7:00 am |
RNS |
Update from iSCIB1+ Clinical Advisory Meeting |
| 10th Jul 2024 7:00 am |
RNS |
Appointment of Dr Florian Reinaud to the Board |
| 2nd Jul 2024 7:00 am |
RNS |
Extension of Convertible Loan Notes |
| 1st Jul 2024 7:00 am |
RNS |
Block Listing Return and Total Voting Rights |
| 21st Jun 2024 7:00 am |
RNS |
Change of Nominated Advisor |
| 12th Jun 2024 7:32 am |
RNS |
Agreement with major biotech |
| 31st May 2024 7:00 am |
RNS |
Scancell to attend upcoming conferences |
| 30th May 2024 7:00 am |
RNS |
Update on ModiFY trial |
| 24th May 2024 7:00 am |
RNS |
Scancell to present at ASCO Annual Meeting |
| 21st May 2024 7:00 am |
RNS |
Issue of share options |
| 16th May 2024 7:00 am |
RNS |
Presenting at the Sachs 10th Annual Oncology Forum |
| 9th May 2024 7:00 am |
RNS |
Scancell presenting at 21st CIMT Annual Meeting |
| 17th Apr 2024 7:00 am |
RNS |
Presenting at the Annual Immuno-Oncology Summit |
| 16th Apr 2024 7:00 am |
RNS |
Block Listing Six Monthly Return |
| 3rd Apr 2024 7:00 am |
RNS |
Employee exercise of share options |
| 2nd Apr 2024 7:00 am |
RNS |
Scancell to Present at 2024 AACR Annual Meeting |
| 28th Mar 2024 1:21 pm |
RNS |
Scancell Appoints WG as Joint Broker |
| 26th Mar 2024 12:22 pm |
RNS |
First iSCIB1+ patient dosed |
| 14th Mar 2024 11:17 am |
RNS |
Appointment of Sath Nirmalananthan to the Board |
| 12th Mar 2024 7:00 am |
RNS |
Scancell Attendance at Upcoming Conferences |
| 4th Mar 2024 7:00 am |
RNS |
Presenting at Next-Gen Immuno-Oncology Conference |
| 20th Feb 2024 7:00 am |
RNS |
Change of Auditor |
| 5th Feb 2024 7:00 am |
RNS |
Directorate Change |
| 30th Jan 2024 7:00 am |
RNS |
Interim Results |
| 26th Jan 2024 7:00 am |
RNS |
Notice of Interim Results and Presentation |
| 17th Jan 2024 1:46 pm |
RNS |
Update on SCOPE trial |
